MEDICINES EVALUATION UNIT LIMITED

The Medicines Evaluation Unit (MEU) is a UK leader in early phase clinical trials in Manchester, with considerable expertise in SAD and MAD trials. They have a state-of-the-art, hospital-based facility, including 36 inpatient beds with cardiac and telemetry monitoring, a Phase I MHRA accredited pharmacy, clinical assessment suite, and numerous outpatient/consultant rooms. The MEU is MHRA Phase I accredited unit and has been part of the scheme since its inception. The MEU has helped to develop many drugs that are now in use. The MEU is well-equipped to undertake large single center early phase healthy volunteer clinical trials and specialist respiratory trials including Asthma, COPD, Cystic Fibrosis, Allergy, Dermatology, Inflammatory, Cardiovascular and Diabetes. The MEU is now at the forefront of testing new climate-friendly inhalers to ensure they are safe and effective for large populations worldwide and to support the transition towards low GWP propellants in devices used for inhaled drug delivery.